Styczynski J - Search Results

1

Differential ex vivo activity of bortezomib in newly diagnosed paediatric acute lymphoblastic and myeloblastic leukaemia.

Szczepanek J, Pogorzala M, Konatkowska B, Juraszewska E, Badowska W, Olejnik I, Kuzmicz M, Stanczak E, Malinowska I, Stefaniak J, Sobol G, Szczepanski T, Czyzewski K, Wysocki M, Styczynski J. Szczepanek J, et al. Among authors: styczynski j. Anticancer Res. 2010 Jun;30(6):2119-24. Anticancer Res. 2010. PMID: 20651360

2

In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia.

Styczynski J, Pieters R, Huismans DR, Schuurhuis GJ, Wysocki M, Veerman AJ. Styczynski J, et al. Br J Haematol. 2000 Sep;110(4):813-8. doi: 10.1046/j.1365-2141.2000.02211.x. Br J Haematol. 2000. PMID: 11054062 Free article.

3

[Bone marrow cellularity in acute lymphoblastic leukemia of children].

Styczyński J, Kubicka M, Langer B, Wysocki M, Debski R, Wolska E, Polańska M. Styczyński J, et al. Wiad Lek. 2000;53(9-10):507-12. Wiad Lek. 2000. PMID: 11148917 Polish.

4

A nine-year experience of immunoprophylaxis against hepatitis B virus infection in children with cancer: results from a single institution in Poland.

Styczynski J, Wysocki M, Koltan S, Kurylak A. Styczynski J, et al. J Hosp Infect. 2001 Aug;48(4):298-303. doi: 10.1053/jhin.2001.1017. J Hosp Infect. 2001. PMID: 11461131

5

Epidemiologic aspects and preventive strategy of hepatitis B and C viral infections in children with cancer.

Styczynski J, Wysocki M, Koltan S, Kurylak A. Styczynski J, et al. Pediatr Infect Dis J. 2001 Nov;20(11):1042-9. doi: 10.1097/00006454-200111000-00008. Pediatr Infect Dis J. 2001. PMID: 11734709

6

[Methotrexate resistance in acute leukemias].

Styczyński J, Wysocki M. Styczyński J, et al. Pol Merkur Lekarski. 2001 Aug;11(62):175-9. Pol Merkur Lekarski. 2001. PMID: 11757224 Review. Polish.

7

Course of viral hepatitis B and combined B and C hepatitis in children treated for neoplastic diseases.

Kołtan S, Wysocki M, Kołtan A, Swiatkiewicz V, Styczyński J, Debski R, Balcar-Boroń A. Kołtan S, et al. Among authors: styczynski j. Med Sci Monit. 2002 Apr;8(4):CR274-9. Med Sci Monit. 2002. PMID: 11951070

8

Dexrazoxane has no impact on sensitivity of childhood leukemic blasts to daunorubicin.

Styczynski J, Wysocki M, Balwierz W, Kowalczyk JR. Styczynski J, et al. Leukemia. 2002 May;16(5):820-5. doi: 10.1038/sj.leu.2402474. Leukemia. 2002. PMID: 11986942

9

In vitro drug resistance profiles of adult acute lymphoblastic leukemia: possible explanation for difference in outcome to similar therapeutic regimens.

Styczynski J, Wysocki M. Styczynski J, et al. Leuk Lymphoma. 2002 Feb;43(2):301-7. doi: 10.1080/10428190290006071. Leuk Lymphoma. 2002. PMID: 11999561

10

In vitro activity of glufosfamide in childhood acute leukemia.

Styczynski J, Wysocki M, Kurylak A, Juraszewska E, Malinowska I, Stanczak E, Płoszynska A, Stefaniak J, Mazur B, Szczepanski T, Ras M. Styczynski J, et al. Anticancer Res. 2002 Jan-Feb;22(1A):247-50. Anticancer Res. 2002. PMID: 12017297

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

308 results

Search Page